Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Obesity

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 80 articles:
HTML format



Single Articles


    May 2020
  1. KASS DA, Duggal P, Cingolani O
    Obesity could shift severe COVID-19 disease to younger ages.
    Lancet. 2020 May 4. pii: S0140-6736(20)31024.
    PubMed    


    January 2020
  2. WILLIAMS R, Aithal G, Alexander GJ, Allison M, et al
    Unacceptable failures: the final report of the Lancet Commission into liver disease in the UK.
    Lancet. 2020;395:226-239.
    PubMed     Abstract available


    December 2019
  3. WELLS JC, Sawaya AL, Wibaek R, Mwangome M, et al
    The double burden of malnutrition: aetiological pathways and consequences for health.
    Lancet. 2019 Dec 13. pii: S0140-6736(19)32472.
    PubMed     Abstract available


  4. HAWKES C, Ruel MT, Salm L, Sinclair B, et al
    Double-duty actions: seizing programme and policy opportunities to address malnutrition in all its forms.
    Lancet. 2019 Dec 13. pii: S0140-6736(19)32506.
    PubMed     Abstract available


  5. POPKIN BM, Corvalan C, Grummer-Strawn LM
    Dynamics of the double burden of malnutrition and the changing nutrition reality.
    Lancet. 2019 Dec 13. pii: S0140-6736(19)32497.
    PubMed     Abstract available


  6. NUGENT R, Levin C, Hale J, Hutchinson B, et al
    Economic effects of the double burden of malnutrition.
    Lancet. 2019 Dec 13. pii: S0140-6736(19)32473.
    PubMed     Abstract available


    October 2019
  7. MUSELLA M, Vitiello A
    The YOMEGA non-inferiority trial.
    Lancet. 2019;394:1412.
    PubMed    


  8. ROBERT M, Maucort-Boulch D, Delaunay D, Disse E, et al
    The YOMEGA non-inferiority trial - Authors' reply.
    Lancet. 2019;394:1412-1413.
    PubMed    


  9. BERGEAT D, Sulpice L, Meunier B, Boudjema K, et al
    The YOMEGA non-inferiority trial.
    Lancet. 2019;394:1411-1412.
    PubMed    


  10. EL FARA H
    The YOMEGA non-inferiority trial.
    Lancet. 2019;394:1411.
    PubMed    


  11. THE LANCET
    Child nutrition: the need for courageous action.
    Lancet. 2019;394:1387.
    PubMed    


  12. MYTTON OT, Fenton-Glynn C, Pawson E, Viner RM, et al
    Protecting children's rights: why governments must be bold to tackle childhood obesity.
    Lancet. 2019 Oct 10. pii: S0140-6736(19)32274.
    PubMed    


  13. XIAO Y, Sun L
    Semaglutide in weight management.
    Lancet. 2019;394:1226.
    PubMed    


  14. WILDING JPH
    Semaglutide in weight management - Author's reply.
    Lancet. 2019;394:1226-1227.
    PubMed    


    August 2019

  15. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence.
    Lancet. 2019 Aug 29. pii: S0140-6736(19)31709.
    PubMed     Abstract available


  16. BARNETT R
    Type 2 diabetes.
    Lancet. 2019;394:557.
    PubMed    


  17. LEVAILLANT M, Lievre G, Baert G
    Ending diabetes in Mexico.
    Lancet. 2019;394:467-468.
    PubMed    


    July 2019

  18. The slowdown in eradicating hunger.
    Lancet. 2019;394:274.
    PubMed    


    April 2019
  19. RENEHAN AG, Lloyd K, Renehan I
    Awareness of the link between obesity and cancer in UK school curricula.
    Lancet. 2019;393:1591-1592.
    PubMed    


    March 2019
  20. MADSBAD S, Holst JJ
    Bariatric surgery-which procedure is the optimal choice?
    Lancet. 2019;393:1263-1264.
    PubMed    


  21. MASA JF, Mokhlesi B, Benitez I, Gomez de Terreros FJ, et al
    Long-term clinical effectiveness of continuous positive airway pressure therapy versus non-invasive ventilation therapy in patients with obesity hypoventilation syndrome: a multicentre, open-label, randomised controlled trial.
    Lancet. 2019 Mar 29. pii: S0140-6736(18)32978.
    PubMed     Abstract available


  22. MURPHY PB, Piper AJ, Hart N
    Obesity hypoventilation syndrome: is less really more?
    Lancet. 2019 Mar 29. pii: S0140-6736(19)30248.
    PubMed    


  23. AZZOPARDI PS, Hearps SJC, Francis KL, Kennedy EC, et al
    Progress in adolescent health and wellbeing: tracking 12 headline indicators for 195 countries and territories, 1990-2016.
    Lancet. 2019;393:1101-1118.
    PubMed     Abstract available


  24. ROBERT M, Espalieu P, Pelascini E, Caiazzo R, et al
    Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial.
    Lancet. 2019 Mar 6. pii: S0140-6736(19)30475.
    PubMed     Abstract available


  25. THE LANCET
    Health and wellbeing in adolescence and early adulthood.
    Lancet. 2019;393:847.
    PubMed    


    February 2019
  26. NUGENT R
    Rethinking systems to reverse the global syndemic.
    Lancet. 2019;393:726-728.
    PubMed    


  27. DA SILVA JG
    Transforming food systems for better health.
    Lancet. 2019;393:e30-e31.
    PubMed    


  28. MENDENHALL E, Singer M
    The global syndemic of obesity, undernutrition, and climate change.
    Lancet. 2019 Feb 11. pii: S0140-6736(19)30310.
    PubMed    


    January 2019
  29. KLEINERT S, Horton R
    Obesity needs to be put into a much wider context.
    Lancet. 2019 Jan 25. pii: S0140-6736(18)33192.
    PubMed    


  30. DAVIES R
    William Dietz: shaping science and policy on obesity.
    Lancet. 2019 Jan 25. pii: S0140-6736(19)30147.
    PubMed    


  31. SWINBURN BA, Kraak VI, Allender S, Atkins VJ, et al
    The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission report.
    Lancet. 2019 Jan 25. pii: S0140-6736(18)32822.
    PubMed    


  32. THE LANCET
    2019: the year for nutrition.
    Lancet. 2019;393:200.
    PubMed    


    December 2018
  33. SANYAL A, Charles ED, Neuschwander-Tetri BA, Loomba R, et al
    Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial.
    Lancet. 2018 Dec 13. pii: S0140-6736(18)31785.
    PubMed     Abstract available


  34. WILLIAMS R, Alexander G, Aspinall R, Batterham R, et al
    Gathering momentum for the way ahead: fifth report of the Lancet Standing Commission on Liver Disease in the UK.
    Lancet. 2018;392:2398-2412.
    PubMed     Abstract available


    November 2018
  35. UNAMUNO X, Fruhbeck G
    Lorcaserin: balancing efficacy with potential risks.
    Lancet. 2018;392:2239-2240.
    PubMed    


    October 2018
  36. TAYLOR R, Adamson AJ, Sattar N, Lean MEJ, et al
    VLCD for weight loss and remission of type 2 diabetes? - Authors' reply.
    Lancet. 2018;392:1307.
    PubMed    


  37. AHMAD N, Alfaris N
    VLCD for weight loss and remission of type 2 diabetes?
    Lancet. 2018;392:1306-1307.
    PubMed    


  38. RALSTON J, Brinsden H, Buse K, Candeias V, et al
    Time for a new obesity narrative.
    Lancet. 2018 Oct 10. pii: S0140-6736(18)32537.
    PubMed    


  39. BOHULA EA, Scirica BM, Inzucchi SE, McGuire DK, et al
    Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial.
    Lancet. 2018 Oct 3. pii: S0140-6736(18)32328.
    PubMed     Abstract available


    August 2018
  40. O'NEIL PM, Birkenfeld AL, McGowan B, Mosenzon O, et al
    Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial.
    Lancet. 2018 Aug 16. pii: S0140-6736(18)31773.
    PubMed     Abstract available


    June 2018
  41. RAYNER CK, Horowitz M
    Agonism of receptors in the gut-pancreas axis in type 2 diabetes: are two better than one?
    Lancet. 2018 Jun 22. pii: S0140-6736(18)30936.
    PubMed    


  42. AMBERY P, Parker VE, Stumvoll M, Posch MG, et al
    MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study.
    Lancet. 2018 Jun 22. pii: S0140-6736(18)30726.
    PubMed     Abstract available


    May 2018
  43. EZZATI M, Di Cesare M, Bentham J
    Determining the worldwide prevalence of obesity - Authors' reply.
    Lancet. 2018;391:1774.
    PubMed    


  44. REILLY JJ, El-Hamdouchi A, Diouf A, Monyeki A, et al
    Determining the worldwide prevalence of obesity.
    Lancet. 2018;391:1773-1774.
    PubMed    


  45. FLEMING TP, Watkins AJ, Velazquez MA, Mathers JC, et al
    Origins of lifetime health around the time of conception: causes and consequences.
    Lancet. 2018;391:1842-1852.
    PubMed     Abstract available


    March 2018
  46. THOMPSON AJ, Baranzini SE, Geurts J, Hemmer B, et al
    Multiple sclerosis.
    Lancet. 2018 Mar 22. pii: S0140-6736(18)30481.
    PubMed     Abstract available


  47. BUCHBINDER R, van Tulder M, Oberg B, Costa LM, et al
    Low back pain: a call for action.
    Lancet. 2018 Mar 20. pii: S0140-6736(18)30488.
    PubMed     Abstract available


    January 2018
  48. ABDULHUSSEIN D, Amin E
    Translation of the link between cancer and obesity to patients.
    Lancet. 2018;391:121-122.
    PubMed    


  49. SELBIE D
    Reducing childhood obesity in the UK.
    Lancet. 2018;391:26.
    PubMed    


  50. BRAILLON A
    Reducing childhood obesity in the UK and France.
    Lancet. 2018;391:26.
    PubMed    


    November 2017
  51. WILLIAMS R, Alexander G, Armstrong I, Baker A, et al
    Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UK.
    Lancet. 2017 Nov 28. pii: S0140-6736(17)32866.
    PubMed     Abstract available


    October 2017
  52. THE LANCET
    The link between cancer and obesity.
    Lancet. 2017;390:1716.
    PubMed    



  53. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults.
    Lancet. 2017 Oct 10. pii: S0140-6736(17)32129.
    PubMed     Abstract available


  54. DIETZ WH
    Double-duty solutions for the double burden of malnutrition.
    Lancet. 2017 Oct 10. pii: S0140-6736(17)32479.
    PubMed    


    September 2017
  55. JURECIC A, Marchalik D
    On obesity: Roxane Gay's Hunger.
    Lancet. 2017;390:1577.
    PubMed    


    August 2017
  56. THE LANCET
    The UK's inadequate plan for reducing childhood obesity.
    Lancet. 2017;390:822.
    PubMed    


    June 2017
  57. ANGADI SS, Gaesser GA
    Body-mass index and all-cause mortality.
    Lancet. 2017;389:2285.
    PubMed    


  58. DI ANGELANTONIO E, Bhupathiraju SN, Hu FB, Danesh J, et al
    Body-mass index and all-cause mortality - Authors' reply.
    Lancet. 2017;389:2285-2286.
    PubMed    


  59. FLEGAL KM
    Body-mass index and all-cause mortality.
    Lancet. 2017;389:2284-2285.
    PubMed    


  60. PEPPER DJ, Sun J, Suffredini AF, Kadri S, et al
    Body-mass index and all-cause mortality.
    Lancet. 2017;389:2284.
    PubMed    


  61. VINER R, White B, Christie D
    Type 2 diabetes in adolescents: a severe phenotype posing major clinical challenges and public health burden.
    Lancet. 2017;389:2252-2260.
    PubMed     Abstract available


    April 2017
  62. KIRCHHOF P
    The future of atrial fibrillation management: integrated care and stratified therapy.
    Lancet. 2017 Apr 28. pii: S0140-6736(17)31072.
    PubMed     Abstract available


  63. AVEYARD P, Nickless A, Jebb S
    Obesity management in primary care - Authors' reply.
    Lancet. 2017;389:1606-1607.
    PubMed    


  64. HIGUCHI A, Kami M
    Obesity management in primary care.
    Lancet. 2017;389:1606.
    PubMed    


  65. STURGISS EA, Haesler E, Elmitt N, Douglas K, et al
    Obesity management in primary care.
    Lancet. 2017;389:1605.
    PubMed    


  66. BOOTH HP, Gulliford MC
    Obesity management in primary care.
    Lancet. 2017;389:1605-1606.
    PubMed    


    February 2017
  67. LE ROUX CW, Astrup A, Fujioka K, Greenway F, et al
    3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.
    Lancet. 2017 Feb 22. pii: S0140-6736(17)30069.
    PubMed     Abstract available


    January 2017
  68. STRINGHINI S, Carmeli C, Jokela M, Avendano M, et al
    Socioeconomic status and the 25 x 25 risk factors as determinants of premature mortality: a multicohort study and meta-analysis of 1.7 million men and women.
    Lancet. 2017 Jan 31. pii: S0140-6736(16)32380.
    PubMed     Abstract available


  69. THE LANCET
    Obesity and diabetes in 2017: a new year.
    Lancet. 2017;389:1.
    PubMed    


    November 2016
  70. ROYO-BORDONADA MA
    Setting up childhood obesity policies in Europe.
    Lancet. 2016;388:2475.
    PubMed    


    October 2016
  71. AVEYARD P, Lewis A, Tearne S, Hood K, et al
    Screening and brief intervention for obesity in primary care: a parallel, two-arm, randomised trial.
    Lancet. 2016 Oct 21. pii: S0140-6736(16)31893.
    PubMed     Abstract available


  72. SWINBURN B, Arroll B
    Rethinking primary care systems for obesity.
    Lancet. 2016 Oct 21. pii: S0140-6736(16)31913.
    PubMed    


  73. AVEYARD P, Lewis A, Tearne S, Hood K, et al
    Screening and brief intervention for obesity in primary care: a parallel, two-arm, randomised trial.
    Lancet. 2016 Oct 21. pii: S0140-6736(16)31893.
    PubMed     Abstract available


  74. SIGMON SC
    Additive burdens of malnutrition, poverty, and substance abuse.
    Lancet. 2016;388:1879-1880.
    PubMed    


  75. LI B, Lin R, Liu W, Chen J, et al
    Differences in perceived causes of childhood obesity between migrant and local communities in China: a qualitative study.
    Lancet. 2016;388 Suppl 1:S3.
    PubMed     Abstract available


    September 2016
  76. LI F, Liu Y, Zhu W, Harmer P, et al
    China's challenges in promoting physical activity and fitness.
    Lancet. 2016;388:1278-9.
    PubMed    


    August 2016
  77. MANN J, Morenga LT, McLean R, Swinburn B, et al
    Dietary guidelines on trial: the charges are not evidence based.
    Lancet. 2016;388:851-3.
    PubMed    


  78. FREEDHOFF Y, Hall KD
    Weight loss diet studies: we need help not hype.
    Lancet. 2016;388:849-51.
    PubMed    


  79. BERRIGAN D, Troiano RP, Graubard BI
    BMI and mortality: the limits of epidemiological evidence.
    Lancet. 2016;388:734-6.
    PubMed    


    July 2016
  80. O'DONNELL MJ, Chin SL, Rangarajan S, Xavier D, et al
    Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study.
    Lancet. 2016 Jul 15. pii: S0140-6736(16)30506.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obesity is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: